CD79A and acute myeloid leukemia: Among AML cases, 9(13%) cases exhibited single aberrant antigenic expression including CD2 (11.1%), CD7 (11.1%), CD19 (55.6%) and CD79a (22.2%) and mean age was reported as 8.2± 4.1 years.